SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 37 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $29,472 | -22.5% | 42,193 | -0.1% | 0.00% | – |
Q4 2022 | $38,009 | -85.0% | 42,232 | -0.1% | 0.00% | – |
Q3 2022 | $254,000 | +61.8% | 42,269 | +11.4% | 0.00% | – |
Q2 2022 | $157,000 | +6.1% | 37,935 | -2.1% | 0.00% | – |
Q1 2022 | $148,000 | -16.4% | 38,758 | -1.3% | 0.00% | – |
Q4 2021 | $177,000 | +18.0% | 39,286 | +22.0% | 0.00% | – |
Q3 2021 | $150,000 | -12.3% | 32,198 | +32.5% | 0.00% | – |
Q2 2021 | $171,000 | -73.4% | 24,300 | -77.7% | 0.00% | – |
Q1 2021 | $642,000 | +13.4% | 108,736 | -11.4% | 0.00% | – |
Q4 2020 | $566,000 | +17.7% | 122,740 | -0.7% | 0.00% | – |
Q3 2020 | $481,000 | -86.8% | 123,574 | -2.7% | 0.00% | -100.0% |
Q2 2020 | $3,652,000 | +186.9% | 127,006 | +114.7% | 0.00% | – |
Q1 2020 | $1,273,000 | +21.7% | 59,154 | +11.3% | 0.00% | – |
Q4 2019 | $1,046,000 | +905.8% | 53,146 | +663.5% | 0.00% | – |
Q3 2019 | $104,000 | – | 6,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |